A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
for Autoimmune Haemolytic Anaemia
23 locations incl. Phoenix
Sponsor: Sanofi
Sex: All·Age: 18+
Code: NCT07086976·Phase 3·Recruiting·Listed Jul 2025